Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

25,258 signal articles · 242 in last 24h · 120,554 total before filter · latest 39m ago
242last 24h
1389last 7d
235● bullish (7d)
150● bearish (7d)
205publishers
AllMacro245Earnings523M&A102Regulatory17Product9Analyst20
✕ clear all filtersSentiment:bullishneutralbearishshow all (incl. clickbait)
Aehr Test (AEHR) Soars as Bullish Outlook Overshadows Weak FY Earnings
Insider Monkey36d agobullish
Aehr Test (AEHR) Soars as Bullish Outlook Overshadows Weak FY Earnings

Aehr Test Systems climbed by 21.91 percent on Wednesday to close at $87.79 apiece, after management projected a sharp acceleration in its full-year growth for fiscal 2027, underpinned by a record backlog and the continued strong demand for semiconductor testing solutions in AI infrastructure. In an earnings call on Tuesday, the company said that it […]

Investing.com36d agoneutral
Morgan Stanley stays bullish on aerospace, defense ahead of Q2 earnings

Investing.com -- Morgan Stanley maintained a constructive outlook on the aerospace and defense sector ahead of second-quarter earnings, citing resilient commercial aerospace demand, improving aircraft production, and favorable long-term defense spending trends, while becoming more selective after recent stock volatility and valuation shifts.

Banks’ Blowout Earnings Steal the Spotlight from Big Tech—for Now
Barrons.com36d agoneutral
Banks’ Blowout Earnings Steal the Spotlight from Big Tech—for Now

Wall Street cleared this earnings season’s first major hurdle with room to spare, as the nation’s biggest banks pummeled profit forecasts. “Bank earnings are often described as a scoreboard for the financial sector,” said Ruben Dalfovo, investment strategist at Saxo Bank. “They are more useful as an economic medical examination, and the early numbers suggest the patient remains active, and dealmaking appears healthier.”

RE/MAX (RMAX): Buy, Sell, or Hold Post Q1 Earnings?
StockStory36d agoneutral
RE/MAX (RMAX): Buy, Sell, or Hold Post Q1 Earnings?

Over the past six months, RE/MAX has been a great trade, beating the S&P 500 by 29.9%. Its stock price has climbed to $11.26, representing a healthy 38.2% increase. This run-up might have investors contemplating their next move.

The PNC Financial Services Group Q2 Earnings Call Highlights
MarketBeat36d agoneutral
The PNC Financial Services Group Q2 Earnings Call Highlights

The PNC Financial Services Group (NYSE:PNC) reported what Chairman and CEO Bill Demchak called an “impressive” second quarter, with management pointing to broad-based business momentum, stronger fee income, continued commercial loan growth and stable credit quality. PNC generated second-quarter net

Aehr Test Systems surge on earnings beat, strong guidance
Proactive36d agobullish
Aehr Test Systems surge on earnings beat, strong guidance

Aehr Test Systems (NASDAQ:AEHR) shares jumped 30% after the semiconductor test and burn-in equipment provider reported fiscal fourth-quarter results that exceeded Wall Street expectations and provided a stronger-than-anticipated revenue outlook for fiscal 2027. The company posted adjusted...

Johnson & Johnson beats Q2 estimates, raises full-year 2026 guidance
Proactive36d agobullish
Johnson & Johnson beats Q2 estimates, raises full-year 2026 guidance

Johnson & Johnson (NYSE:JNJ) reported better-than-expected second quarter results and raised its full-year 2026 outlook, as strong pharmaceutical sales helped offset headwinds from products facing patent competition. The healthcare company posted adjusted earnings per share of $2.90 for...